Prostate cancer risk reduced with statin use

MEN being treated with statins may be getting a side benefit in reduced risk of prostate cancer, research suggests.

In a cohort of almost 56,000 US veterans with a mean age of 66 years, researchers found the men taking statins were 31% less likely to be diagnosed with prostate cancer than those taking antihypertensives.

Higher total cholesterol was associated with higher prostate cancer risk.

The findings were consistent with the hypothesis that cholesterol plays an important role in prostate cancer incidence, the authors said.

They called for clinical trials of statins for prostate cancer prevention, an idea supported by Dr Stephen Ruthven, vice-president of the Urological Society of Australia and New Zealand. 

“It is exciting to think… a very commonly prescribed drug… may have an unintended but welcome reduction in prostate cancer,” he said, but added the jury was out until a large randomised